<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39430766</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Case report: Rare Guillain-Barré syndrome variants and mild encephalitis/encephalopathy with a reversible splenial lesion as the para-infectious manifestations of SARS-CoV-2 infection.</ArticleTitle><Pagination><StartPage>1458231</StartPage><MedlinePgn>1458231</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1458231</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2024.1458231</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The Coronavirus disease 19 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a threat to human health. Although the COVID-19 pandemic is finished, some peoples are still suffering from this disease. Herein, we report the first case of SARS-CoV-2-associated Guillain-Barré syndrome (GBS) presenting as polyneuritis cranialis (PNC) and acute panautonomic neuropathy (APN) variants, accompanied by mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) and hyponatremia.</AbstractText><AbstractText Label="CASE PRESENTATION" NlmCategory="UNASSIGNED">A 32-year-old female patient with symptoms indicating multiple cranial nerve involvement, as well as sympathetic and parasympathetic nervous system dysfunction, was diagnosed as SARS-CoV-2-associated GBS presenting as PNC and APN variants, accompanied by MERS and hyponatremia. Following treatment with immunoglobulin, methylprednisolone, and symptomatic care, the patient's inflammatory cytokines and serum sodium became normal. However, some residual symptoms such as postural hypotension, fatigue, and mild dysarthria persisted at the 9-month follow-up.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">This case highlights the unique presentation of SARS-CoV-2 infection. The involvement of both the central nervous system (CNS) and the peripheral nervous system (PNS) in this case underscores the complex neurological manifestations of COVID-19. Although the exact underlying pathogenesis of this case is unclear, inflammatory cytokines, particularly IL-6, may be implicated. Further research is needed to better understand the mechanisms underlying these complications and to optimize treatment strategies for affected patients.</AbstractText><CopyrightInformation>Copyright © 2024 Si, Li and Du.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Si</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology, Luoyang, Henan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yuanrui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology, Luoyang, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Ganqin</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurology, The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology, Luoyang, Henan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020275" MajorTopicYN="Y">Guillain-Barre Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004660" MajorTopicYN="N">Encephalitis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003337" MajorTopicYN="N">Corpus Callosum</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007010" MajorTopicYN="N">Hyponatremia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001927" MajorTopicYN="N">Brain Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Guillain-Barré syndrome</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">acute panautonomic neuropathy</Keyword><Keyword MajorTopicYN="N">case report</Keyword><Keyword MajorTopicYN="N">polyneuritis cranialis</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>13</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>10</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>5</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39430766</ArticleId><ArticleId IdType="pmc">PMC11486701</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2024.1458231</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Censi S, Bisaccia G, Gallina S, Tomassini V, Uncini A. Guillain-Barré syndrome and SARS-CoV-2 infection: a systematic review and meta-analysis on a debated issue and evidence for the ‘Italian factor’. Eur J Neurol. (2024) 31:e16094. doi: 10.1111/ene.16094</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.16094</ArticleId><ArticleId IdType="pmc">PMC11235836</ArticleId><ArticleId IdType="pubmed">37823707</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutiérrez-Ortiz C, Méndez-Guerrero A, Rodrigo-Rey S, San Pedro-Murillo E, Bermejo-Guerrero L, Gordo-Mañas R, et al. . Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. (2020) 95:e601–5. doi: 10.1212/WNL.0000000000009619</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009619</ArticleId><ArticleId IdType="pubmed">32303650</ArticleId></ArticleIdList></Reference><Reference><Citation>Gradišnik P, Koprivšek AO, Rus M, Golli T, Damjan H. Polyneuritis cranialis related to SARS-CoV-2 infection: a case report. Acta Medico-Biotechnica. (2023) 16:53–6. doi: 10.18690/actabiomed.251</Citation><ArticleIdList><ArticleId IdType="doi">10.18690/actabiomed.251</ArticleId></ArticleIdList></Reference><Reference><Citation>Malekpour M, Khanmohammadi S, Meybodi MJE, Shekouh D, Rahmanian MR, Kardeh S, et al. . COVID-19 as a trigger of Guillain-Barré syndrome: A review of the molecular mechanism. Immun Inflammation Dis. (2023) 11:e875. doi: 10.1002/iid3.875</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.875</ArticleId><ArticleId IdType="pmc">PMC10187022</ArticleId><ArticleId IdType="pubmed">37249286</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson RW, Brown RL, Benjamin L, Nortley R, Wiethoff S, Bharucha T, et al. . The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. (2020) 143:3104–20. doi: 10.1093/brain/awaa240</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa240</ArticleId><ArticleId IdType="pmc">PMC7454352</ArticleId><ArticleId IdType="pubmed">32637987</ArticleId></ArticleIdList></Reference><Reference><Citation>Pimentel V, Luchsinger VW, Carvalho GL, Alcará AM, Esper NB, Marinowic D, et al. . Guillain-Barré syndrome associated with COVID-19: A systematic review. Brain Behav Immun Health. (2023) 28:100578. doi: 10.1016/j.bbih.2022.100578</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2022.100578</ArticleId><ArticleId IdType="pmc">PMC9842533</ArticleId><ArticleId IdType="pubmed">36686624</ArticleId></ArticleIdList></Reference><Reference><Citation>Thepmankorn P, Bach J, Lasfar A, Zhao X, Souayah S, Chong ZZ, et al. . Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations. Cytokine. (2021) 138:155404. doi: 10.1016/j.cyto.2020.155404</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2020.155404</ArticleId><ArticleId IdType="pmc">PMC7832981</ArticleId><ArticleId IdType="pubmed">33360025</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokano M, Tarumoto N, Osawa I, Sakai J, Okada M, Seo K, et al. . A case of COVID-related MERS (clinically mild encephalitis/encephalopathy with a reversible splenial lesion) with a typical imaging course and hyponatremia in adults—A case report and literature review. COVID. (2023) 3:183–91. doi: 10.3390/covid3020013</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/covid3020013</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito M, Nakazawa T, Toriumi S, Takasu M, Yagisawa H, Murano Y, et al. . Case report: Mild encephalitis with a reversible splenial lesion associated with SARS-CoV-2 infection in a patient with MYRF variant. Front Pediatr. (2022) 10:971432. doi: 10.3389/fped.2022.971432</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.971432</ArticleId><ArticleId IdType="pmc">PMC9386134</ArticleId><ArticleId IdType="pubmed">35990002</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakadia B, Ahmed J, Siegal T, Jovin TG, Thon JM. Mild encephalopathy with reversible splenium lesion (MERS) in a patient with COVID-19. J Clin Neurosci. (2020) 79:272–4. doi: 10.1016/j.jocn.2020.07.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2020.07.009</ArticleId><ArticleId IdType="pmc">PMC7340073</ArticleId><ArticleId IdType="pubmed">33070911</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagae K, Haraguchi M, Sakoh T, Ishida K, Ogura S, Katoh-Morishima M, et al. . A case of mild encephalitis associated with COVID-19. J Gen Fam Med. (2023) 24:307–10. doi: 10.1002/jgf2.646</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jgf2.646</ArticleId><ArticleId IdType="pmc">PMC10506395</ArticleId><ArticleId IdType="pubmed">37727618</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi M, Ueda M, Hayashi K, Kawahara E, Azuma SI, Suzuki A, et al. . Case report: Clinically mild encephalitis/encephalopathy with a reversible splenial lesion: an autopsy case. Front Neurol. (2024) 14:1322302. doi: 10.3389/fneur.2023.1322302</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1322302</ArticleId><ArticleId IdType="pmc">PMC10794512</ArticleId><ArticleId IdType="pubmed">38239318</ArticleId></ArticleIdList></Reference><Reference><Citation>Duloquin G, Pommier T, Georges M, Giroud M, Guenancia C, Béjot Y, et al. . Is COVID-19 infection a multiorganic disease? Focus on extrapulmonary involvement of SARS-coV-2. J Clin Med. (2024) 13:1397. doi: 10.3390/jcm13051397</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm13051397</ArticleId><ArticleId IdType="pmc">PMC10932259</ArticleId><ArticleId IdType="pubmed">38592697</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes CZA, Kokash A, Yacoub HA. Mild encephalopathy with partial reversible splenium lesion associated with SARS-coV-2 infection. Cureus. (2023) 15:e36421. doi: 10.7759/cureus.36421</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.36421</ArticleId><ArticleId IdType="pmc">PMC10115355</ArticleId><ArticleId IdType="pubmed">37090308</ArticleId></ArticleIdList></Reference><Reference><Citation>Swart RM, Hoorn EJ, Betjes MG, Zietse R. Hyponatremia and inflammation: the emerging role of interleukin-6 in osmoregulation. Nephron Physiol. (2011) 118:45–51. doi: 10.1159/000322238</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000322238</ArticleId><ArticleId IdType="pubmed">21196778</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>